ArticleKidney international reports2026
Optimization of Kidney Disease: Improving Global Outcomes Criteria for AKI for Pediatric Population.
Article in Kidney international reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Accurate detection and staging of acute kidney injury (AKI) is important in clinical practice to aid timely management. The main purpose of this study is to establish a pediatric version of Kidney Disease: Improving Global Outcomes (KDIGO, pKDIGO) criteria for pediatric population. Methods: The pKDIGO criteria defined AKI following the principles of KDIGO, in which the threshold of absolute increase in serum creatinine (SCr) or absolute decrease in estimated glomerular filtration rate (GFR, eGFR) to diagnose AKI has been revised to eliminate the impacts of age and sex of children. Then, AKI defined by pKDIGO were compared with that defined by KDIGO, modified KDIGO (mKDIGO), pediatric reference change value optimized for AKI in children (pROCK), and pediatric Risk for renal dysfunction, Injury to the kidney, Failure of kidney function, Loss of kidney function, and End-stage renal disease (RIFLE, pRIFLE) based on 2 retrospective cohorts in China: Beijing Children's Hospital (BCH) cohort and intensive care units (ICUs) of the Children's Hospital of Zhejiang University School of Medicine (ICU) cohort. The performance of different AKI definitions was compared based on the area under the receiver operating characteristic curves (AUCs) for predicting the in-hospital death. Results: Total of 57,229 children in the BCH cohort and 8276 children in the ICU cohort were used to evaluate the performance of pKDIGO. In the BCH cohort, AUCs for predicting mortality by AKI defined based on pKDIGO (AUC = 0.75, 0.72-0.78) were higher than that defined by other definitions. The risk of death increases with higher stage of AKI defined by pKDIGO. Similar results were observed in the ICU cohort. Conclusion: The pKDIGO criteria showed a better ability to identify patients with AKI and predict in-hospital death in children, both in general wards and ICUs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.